(Q48365362)

11 February 2018

review article

1 reference

title

Clonidine-displacing substance and its putative role in control of insulin secretion: a minireview. (English)

1 reference

11 February 2018

author name string

Chan SL

series ordinal

1

1 reference

11 February 2018

publication date

1 October 1998

1 reference

11 February 2018

published in

General Pharmacology

1 reference

11 February 2018

volume

31

1 reference

11 February 2018

page(s)

525-529

1 reference

11 February 2018

issue

4

1 reference

11 February 2018

Clonidine-displacing substance (CDS) and its putative imidazoline receptor. New leads for further divergence of alpha 2-adrenergic receptor activity

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

Molecular and physiological properties of clonidine-displacing substance

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

Isolation of an endogenous clonidine‐displacing substance from rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

Polyclonal anti-idazoxan antibodies: characterization and purification

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

Agmatine is not a good candidate as endogenous ligand for imidazoline sites of pancreatic B cells and vascular bed

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

An endogenous, non-catecholamine clonidine antagonist increases mean arterial blood pressure.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

Role of alpha 2-adrenoceptors and imidazoline-binding sites in the control of insulin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

Stimulation of insulin secretion by efaroxan may involve interaction with potassium channels

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

Stimulation of insulin secretion by the imidazoline α2-adrenoceptor antagonist efaroxan is mediated by a novel, stereoselective, binding site

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

The imidazoline site involved in control of insulin secretion: characteristics that distinguish it from I1- and I2-sites.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

The effect of the putative endogenous imidazoline receptor ligand, clonidine-displacing substance, on insulin secretion from rat and human islets of Langerhans

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

Evidence that the ability of imidazoline compounds to stimulate insulin secretion is not due to interaction with sigma receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

An endogenous brain substance, CDS (clonidine-displacing-substance), inhibits the twitch response of rat vas deferens.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

A low molecular weight brain substance interacts, similarly to clonidine, with alpha 2-adrenoceptors of human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

Production and characterization of anti-clonidine antibodies not cross-reacting with catecholamines

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

A circulating substance cross-reacting with antiimidazoline antibodies. Detection in serum in relation to essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

Block of ATP-regulated potassium channels by phentolamine and other α-adrenoceptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

Clonidine displacing substance is biologically active on smooth muscle.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

über Synthetisch Dargestellte Körper mit Insulinartiger Wirkung Auf den Normalen und Diabetischen Organismus

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

Detection and measurement of an endogenous clonidine-displacing substance in human cerebrospinal fluid.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

Block of pancreatic ATP-sensitive K+ channels and insulinotrophic action by the antiarrhythmic agent, cibenzoline

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

Agmatine, a novel hypothalamic amine, stimulates pituitary luteinizing hormone release in vivo and hypothalamic luteinizing hormone-releasing hormone release in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

Stimulation of insulin release from the MIN6 cell line by a new imidazoline compound, S-21663: evidence for the existence of a novel imidazoline site in beta cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

Agmatine: an endogenous clonidine-displacing substance in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

An endogenous clonidine-displacing substance from bovine brain: receptor binding and hypotensive actions in the ventrolateral medulla.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

Evidence for a bioactive clonidine-displacing substance in peripheral tissues and serum.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

Characterization of the imidazoline binding site involved in regulation of insulin secretion.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

Imidazolines stimulate release of insulin from RIN-5AH cells independently from imidazoline I1 and I2 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

The elusive family of imidazoline binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

Agmatine does not have activity at alpha 2-adrenoceptors which modulate the firing rate of locus coeruleus neurones: an electrophysiological study in rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

Phentolamine and yohimbine inhibit ATP-sensitive K+ channels in mouse pancreatic beta-cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

Agmatine, the bacterial amine, is widely distributed in mammalian tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

Imidazoline receptors and their endogenous ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

Endogenous ligands of imidazoline receptors: classic and immunoreactive clonidine-displacing substance and agmatine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

Imidazoline/guanidinium binding sites and their relation to inhibition of K(ATP) channels in pancreatic B-cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

Stimulus-secretion coupling of arginine-induced insulin release. Insulinotropic action of agmatine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

Quantitation of the putative neurotransmitter agmatine as the hexafluoroacetylacetonate derivative by stable isotope dilution gas chromatography and negative-ion chemical ionization mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

Human plasma-derived material with clonidine displacing substance (CDS)-like properties contracts the isolated rat aorta

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

An endogenous ligand for the central sulfonylurea receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

Endosulfine, an endogenous peptidic ligand for the sulfonylurea receptor: purification and partial characterization from ovine brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

Endosulfine, endogenous ligand for the sulphonylurea receptor: isolation from porcine brain and partial structural determination of the alpha form.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900052-4

7 January 2021

10.1016/S0306-3623(98)00052-4

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

9792210

1 reference

11 February 2018